<sup>99</sup>Tc<sup>m</sup>-MIBI显像检测乳腺癌P-糖蛋白

赵韬

⁹⁹Tc^m-MIBI显像检测乳腺癌P-糖蛋白

赵韬

文章导航 > 国际放射医学核医学杂志 > 2004, 28 > 6: (262-264)

引用本文:

Citation:

⁹⁹Tc^m-MIBI显像检测乳腺癌P-糖蛋白

赵韬

214400 江苏江阴, 东南大学医学院附属江阴医院
中图分类号: R817.4

Application of ⁹⁹Tc^m-MIBI scintimammography to diagnose P-gP of breast cancer

ZHAO Tao

Department of Medical Oncology, Jiangyin Hospital, Southeast University, Jiangyin Jiangsu, 214400, China
CLC number: R817.4

摘要: 探讨了乳腺癌多药耐药的主要机制和⁹⁹Tc^m-MIBI SPECT检测P-糖蛋白在多药耐药中的研究进展。作为一种功能显像技术,⁹⁹Tc^m-MIBI SPECT能够无创伤性检测乳腺癌多药耐药,为临床治疗提供参考。
- ⁹⁹Tc^m-甲氧异丁基异腈 /
- 多药耐药 /
- P-糖蛋白
Abstract: The article discuss the advances in ⁹⁹Tc^m-sestamibi scintimammography to diagnose P-gly-coprotein of breast cancer in multidrug resistance. As a kind of noninvasive fuctional test imaging technology, SPECT can be used to diagnose P-glycoprotein expression in breast cancer and can make decision for clinical treatment.
- ⁹⁹Tc^m-sestamibi /
- multidrug resistance /
- P-glycoprotein
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,2003.85.
[2]	Galimberti S,Marchetti A,Buttitta F,et al.Multidrug resistance related genes and p53 expression in human NSCLC[J].Anticancer Res,1998,18(4C):2973-2976.
[3]	Trock BJ,Ceonessa F,Clarke R,et al.Multidrug resistance in breast cancer:A Meta-analysis of MDR1/gp-170 expression and its possible fuctional significance[J].J Natl Cancer Inst,1997,89:917-931.
[4]	王树滨,刘雅洁,隋广杰等.P-糖蛋白在乳腺癌组织中的表达与预后的关系[J].中国肿瘤临床,2001,28(5):325-328.
[5]	Cordobes MD,Starze A,Delmon-Moingeon L,et al.Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells:Corre lation with mdr gene expression[J].J Nucl Med,1996,37:286-289.
[6]	Vecchio SD,Ciarmiello A,Leonardo P,et al.Fractional retention of the technetium-99m-sestamibi as an index of P-glycoprotein rxpres-sion in untreated breast cancer patients[J].J Nucl Med,1997,38(9):1348-1351.
[7]	Kostakoglu L,Elahi N,Kiratli P,et al.Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors[J].J Nucl Med,1997,38(7):1003-1008.
[8]	Nishiyama Y,Kawasaki Y,Yamamoto Y,et al.Technetium-99m-MIBI and thailium-201 scimtigraphy of primary lung cancer[J].J Nucl Med,1997,38(9):1358-1361.
[9]	Chia-Hung K,Shih-Chuan T,Liu TG,et al.P-glycpprotein and multidrug-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammorgraphy findings[J].Cancer Res,2001,15(61):1412-1414.
[10]	Shung-Shung S,Tih-Fang H,Shih-chuan T,et al.Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results[J].Cancer Lett,2000,153(1-2):95-100.
[11]	Del-Vecchio S,Ciarmiello A,Pue L,et al.Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients[J].J Nucl Med,1997,38(9):1348-1351.
[12]	Del-Vecchio S,Ciarmiello A,Potena MI,et al.In Vivo detection of multidrug-resistance (MDR1) phenotype by technetium-99m ses-tamibi scan in untreated breast cancer patients[J].Eur J Nucl Med,1997,24(2):150-159.
[13]	Muriel A,Noreli F,Jean-Marc R,et al.Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer[J].Breast Cancer Res Trea,2000,61(1):13-20.
[14]	Van de Vijver MJ,He YD,vant Veer LJ,et al.A gene-expression signature as a predictor of survival in breast cancer[J].Engl J Med,2002,347(25):1999-2009.

[1]	钱习军 . ⁹⁹Tc^m-MIBI显像对肿瘤多药耐药检测的应用. 国际放射医学核医学杂志, 2002, 26(4): 173-176.
[2]	程兵 . ⁹⁹Tc^m-MIBI显像检测乳腺癌多药耐药. 国际放射医学核医学杂志, 2002, 26(2): 67-71.
[3]	白景明 , 李亚明 . 体内多药耐药的显像研究. 国际放射医学核医学杂志, 1999, 23(5): 208-212.
[4]	袁超 , 李卫鹏 . ⁹⁹Tc^m-tetrofosmin:一种评价体内P-糖蛋白功能变化的显像剂. 国际放射医学核医学杂志, 2009, 33(3): 144-148. doi: 10.3760/cma.j.issn.1673-4114.2009.03.005
[5]	黄建敏 , 曲雁 , 潘莉萍 . 恶性骨肿瘤多药耐药的⁹⁹Tc^m-MIBI体层显像研究. 国际放射医学核医学杂志, 2005, 29(4): 169-170.
[6]	贾志云 , 邓候富 . ⁹⁹Tc^m-甲氧基异丁基异腈显像在白血病中的应用价值. 国际放射医学核医学杂志, 2005, 29(6): 252-254.
[7]	何燕 , 苏晋 , 郑晓霞 , 温莉 , 孙树兰 . P-糖蛋白抑制剂在PET显像中的应用研究. 国际放射医学核医学杂志, 2016, 40(1): 1-5, 21. doi: 10.3760/cma.j.issn.1673-4114.2016.01.001
[8]	白旭东 , 唐志刚 , 王学斌 . ⁹⁹Tc^m标记异腈类配合物的研究进展. 国际放射医学核医学杂志, 2005, 29(1): 19-22.
[9]	陈伟君 , 孙达 . ⁹⁹Tc^m-MIBI显像在乳腺癌新辅助化疗中的应用价值. 国际放射医学核医学杂志, 2015, 39(6): 487-492. doi: 10.3760/cma.j.issn.1673-4114.2015.06.011
[10]	张一秋 , 石洪成 . ⁹⁹Tc^m-甲氧基异丁基异腈SPECT预测肺癌多药耐药及化疗疗效. 国际放射医学核医学杂志, 2008, 32(6): 329-332.